Invesco
LENZ

Invesco’s LENZ Therapeutics LENZ Stock Holding History

Invesco’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Buy
14,927
+881
+6% +$12.4K ﹤0.01% 3583
2025
Q4 		$225K Sell
14,046
-350,219
-96% -$10.2M ﹤0.01% 3487
2025
Q3 		$17M Buy
364,265
+97,585
+37% +$3.59M ﹤0.01% 1534
2025
Q2 		$7.82M Buy
+266,680
New +$7.25M ﹤0.01% 1937
2024
Q1 		– Sell
-1,917
Closed -$35.2K – 3952
2023
Q4 		$35.2K Buy
1,917
+234
+14% +$3.86K ﹤0.01% 3780
2023
Q3 		$29.2K Buy
1,683
+4
+0.2% +$70 ﹤0.01% 3834
2023
Q2 		$30.6K Buy
+1,679
New +$33.5K ﹤0.01% 3847

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Invesco's LENZ Position: Q1 2026 in Review

Invesco increased its LENZ Therapeutics (LENZ) stake by 6.3% in Q1 2026, buying an estimated $12.4K and bringing the position to 14,927 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #3583.

Invesco first reported a position in LENZ in Q2 2023 and has held it in 7 quarters since. The position peaked at $17M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Invesco held 14,927 shares of LENZ Therapeutics worth $137K as of Q1 2026.
  • Invesco bought 881 LENZ Therapeutics shares in Q1 2026, an estimated $12.4K.
  • LENZ Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3583 holding.
  • Invesco first reported a position in LENZ Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • Invesco's LENZ Therapeutics position peaked at $17M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.